Nav: Home

What are trends in emergency department utilization, costs for shingles?

June 21, 2017

A new article published by JAMA Dermatology uses a nationwide database of emergency department (ED) visits to examine herpes zoster (HZ, shingles)-related ED utilization and costs.

HZ can develop in anyone who has had varicella (chicken pox) or gotten the varicella vaccine, although the risk is lower in those who were vaccinated. The chicken pox vaccine was introduced into the U.S. vaccination schedule in 1995 for children 12 months or older. A vaccine for HZ has been available in the United States since 2006 and it can reduce the likelihood of developing HZ in adults 60 and older, for whom vaccination is recommended.

Arash Mostaghimi, M.D., M.P.A., M.P.H., of Harvard Medical School and Brigham and Women's Hospital, Boston, and coauthors identified more than 1.3 million HZ-related ED visits from 2006 through 2013, representing 0.13 percent of all ED visits in the United States.

Between 2006 and 2013, the percentage of HZ-related ED visits increased from 0.13 percent to 0.14 percent (8.3 percent) and that growth was driven by patients 20 to 59 years old. HZ-related ED visits decreased for patients ages 18 to 19 and for patients 60 and older. For all age groups, overall average charges for HZ-related ED visits increased from $763 to $1,262, according to the results.

"Our study found an increase in total ED visits associated with HZ between 2006 and 2013 due to an increased number of visits by patients aged 20 to 59 years. Despite decreased utilization in paitents aged less than 20 years and 60 years or older, we found increased total adjusted charges in these populations. Our findings suggest that vaccination may be associated with a reduction of ED utilization. Further research is necessary to identify the drivers of increased costs," the study concludes.

Researchers caution their study doesn't allow them to directly link the change in utilization to vaccination.
-end-
For more details and to read the full study, please visit the For The Media website.

(doi:10.1001/jamadermatol.2017.1546)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

To place an electronic embedded link in your story: Links will be live at the embargo time: http://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2017.1546

The JAMA Network Journals

Related Vaccination Articles:

Researchers develop microneedle patch for flu vaccination
A National Institutes of Health-funded study led by a team at the Georgia Institute of Technology and Emory University has shown that an influenza vaccine can produce robust immune responses and be administered safely with an experimental patch of dissolving microneedles.
Rotavirus vaccination in infants and young children
Rotaviruses (RV) are the commonest cause of diarrhea in infants and young children worldwide.
Industry and occupation affect flu vaccination coverage
Not surprisingly, healthcare workers are almost twice as likely to get flu vaccines as those in other occupations.
Child's vaccination data handily available via Kasvuseula service
Parents can now follow their tots' vaccinations via the Kasvuseula online service, which provides analytical data on the child's growth.
Foot-and-mouth crises to be averted with vaccination strategy
Future outbreaks of foot-and-mouth disease (FMD) can be controlled effectively and quickly with vaccinations -- saving millions of pounds and hundreds of thousands of livestock -- according to research by the University of Warwick.
HPV prevalence rates among US men, vaccination coverage
Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the United States, as well as a cause of various cancers, and a new study published online by JAMA Oncology estimates the overall prevalence of genital HPV infection in men ages 18 to 59.
Anesthetic cream best for relieving vaccination pain in infants
For babies under age one year, lidocaine cream, combined with a small amount of sugar given by mouth and infant soothing, can help relieve pain from routine vaccinations, according to a study in Canadian Medical Association Journal.
Measles prevention -- how to pull the trigger for vaccination campaigns?
Routine vaccination has greatly reduced measles deaths in recent years, but very high vaccination coverage is needed to prevent disease outbreaks.
Using satellite images to better target vaccination
Vaccination campaigns can improve prevention and control of disease of outbreaks in the developing world by using satellite images to capture short-term changes in population size.
Maternal vaccination again influenza associated with protection for infants
How long does the protection from a mother's immunization against influenza during pregnancy last for infants after they are born?

Related Vaccination Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".